Back

To pre treat or not to pre treat in ACS?

16 October 2016 (11:22 - 11:45)
Organised by:
Congress Presentation Part of: Dilemmas in anti thrombotic therapy Antithrombotic agents ACVC Premium Access Acute Cardiovascular Care 2016

About the speaker

Photo
Associate Professor Shlomi Matetzky

Sheba Medical Center, Ramat Gan (Israel)

3 More presentations in this session

Presentation thumbnail
New tools to manage bleeding under NOACS.
Professor K. Huber (Vienna, AT)
Slides Video
Presentation thumbnail
Anti thrombotic choices after bleeding.
Professor S. Halvorsen (Oslo, NO)
Slides Video
Presentation thumbnail
Optimal duration of dual antiplatelet therapy study after ACS.
Professor J. Morais (Leiria, PT)
Slides Video

Access the full session

Session thumbnail
Dilemmas in anti thrombotic therapy

The Event

Event poster

Acute Cardiovascular Care 2016

16 October 2016 11:22 CET
You may be interested in
thumbnail
Congress Presentation
Do we pre-treat as intended?
21 March 2026
thumbnail
Webinar
Antithrombotic strategy for ACS: from default to alternative strategies. ESC 2023 Clinical Practice Guidelines - Webinar Series
28 November 2023
thumbnail
Congress Presentation
Plaque erosion: an important mechanism of ACS: current concepts and contemporary management – discussion.
29 August 2022
thumbnail
Congress Presentation
Pre-treatment with P2Y12 inhibitors in acute myocardial infarction with cardiogenic shock
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources